We used an electronic search method to identify the medical records of patients treated at our hospital. The patients’ medical records and radiological images were retrospectively reviewed in the electronic database of our institution by assessing preoperative characteristics, postoperative hemorrhage, additional interventions, mortality, and postoperative complications (such as hepatic failure, abscess, or infarct).
There is a high prevalence of viral hepatitis in Taiwan; viral hepatitis induces liver cirrhosis (a calculated annual incidence of 2.4%) [13 (link),14 (link)], which subsequently causes portal hypertension and affects the entire liver perfusion. Because liver perfusion via the hepatic artery is sacrificed after TAE and may cause severe post-TAE complications, such as liver infarction, secondary liver abscesses, and hepatic failure, we included underlying liver disease (such as liver cirrhosis and any liver-related surgery) to evaluate their association with post-TAE complications.
All the patients’ vital signs were closely monitored, some through laboratory blood tests (especially in relation to liver function), in the intensive care unit after the TAE procedure. If patients showed any clinical signs or symptoms suggesting re-bleeding, repeated angiography with subsequent embolization was performed. The follow-up duration was measured from the time of surgery until death or after discharge, until 30 June 2022 (more than 6 months). No patient was lost to the follow-up.